Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT

    Alfredo Marzano
    e2009025
    https://doi.org/10.4084/mjhid.2009.025
    863
    PDF: 490
    HTML: 1308
  • Tenofovir as Rescue Therapy Following Clinical Failure to Lamivudine in Severe Acute Hepatitis B

    Jurgen Gerada, Elaine Borg, Denise Formosa, Rosalie Magro, James Pocock
    e2013035
    2013-06-03
    https://doi.org/10.4084/mjhid.2013.035
    2143
    PDF: 831
    HTML: 1643
    Figure 1: 552
  • PREVENTION AND TREATMENT OF HEPATITIS VIRUS INFECTION IN HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS

    Suparno Chakrabarti, Somnath Mukherjee
    e2009017
    2009-12-10
    https://doi.org/10.4084/mjhid.2009.017
    840
    PDF: 562
    HTML: 2461
  • HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT

    Anna Locasciulli, Barbara Montante, Emanuela Morelli, Virginia Gulino, Anna Proia, Maria Beatrice Pinazzi
    e2009016
    https://doi.org/10.4084/mjhid.2009.016
    991
    PDF: 541
    HTML: 728
  • Severe Acute Hepatitis B Treated with Entecavir

    Giuseppe Vittorio Luigi De Socio, Alessio Sgrelli, Andrea Tosti, Franco Baldelli
    e2011010
    2011-03-14
    https://doi.org/10.4084/mjhid.2011.010
    1568
    PDF: 807
    HTML: 2501
    Figure: 174
    Title page: 176
    disclosure: 104
  • ENDOTHELIAL NITRIC OXIDE SYNTHASE (ENOS) GENE POLYMORPHISM IS ASSOCIATED WITH AGE ONSET OF MENARCHE IN SICKLE CELL DISEASE FEMALES OF INDIA

    Sudhansu Sekhar Nishank
    e2013036
    2013-06-04
    https://doi.org/10.4084/mjhid.2013.036
    1554
    PDF: 936
    HTML: 2374
    Table: 194
  • Successful management of pregnancy and hepatic toxicity in a CML female patient treated with nilotinib : a case report and a review

    Domenico Santorsola, Elisabetta Abruzzese
    e2015020
    2015-02-12
    https://doi.org/10.4084/mjhid.2015.020
    2034
    PDF: 1229
    HTML: 1636
  • Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients

    Alfredo Marzano, Andrea Marengo, Michela di Fonzo, Antonella Ferrari, Bruno Monarca, Gianfranco delle Fave, Massimo Marignani
    e2010035
    2010-12-13
    https://doi.org/10.4084/mjhid.2010.035
    959
    PDF: 575
    HTML: 2198
    Cover Letter: 196
  • HEMATOPOIETIC STEM CELL TRANSPLANTATION IN EGYPT CHALLENGES AND OPPORTUNITIES

    Hossam Kamel Mahmoud, Gamaleldin Mohamed Fathy, Alaa Elhaddad, Omar Abdelrahman Fahmy, Mohamed Abdelmooti, Raafat Abdelfattah, Mahmoud Tarek Sayed Ahmed Bokhary
    e2020023
    2020-04-27
    https://doi.org/10.4084/mjhid.2020.023
    1866
    PDF: 990
    HTML: 786
  • NUCLEOTIDE SUBSTITUTIONS IN HEPATITIS B VIRUSES DERIVED FROM CHRONIC HBV PATIENTS

    Narjes Shokatpour, Maryam Vaezjalali, Graham R Foster, Shahnaz Sali
    e2019046
    2019-06-24
    https://doi.org/10.4084/mjhid.2019.046
    1204
    PDF: 698
    HTML: 204
  • High level of HBV DNA virus in the breast milk seems not to contraindicate breastfeeding

    Ana Montoya-Ferrer, Astrid Marina Zorrilla, Johannes Viljoen, Jean Pierre Moles, Marie-Louise Newell, Philippe Van de Perre, Edouard Tuaillon
    e2015042
    2015-07-01
    https://doi.org/10.4084/mjhid.2015.042
    2215
    PDF: 832
    HTML: 957
    Untitled: 273
  • DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.

    Maria Concetta Postorino, Filippo Luciani, Carmelo Mangano, Maria Stella Carpentieri, Paolo Scerbo, Armando Priamo, Giuseppina Berardelli, Roberto Marino, Alfredo Vallone, Nicola Serrao, Vincenzo Pisani, Chiara Costa, Albano Terremoto, Giuseppe Foti, Lucio Cosco, Massimo Calderazzo, Domenico Corigliano, Preziosa Scordo, Carlo Torti, Alessio Strazzulla
    e2015054
    2015-10-08
    https://doi.org/10.4084/mjhid.2015.054
    1617
    PDF: 809
    HTML: 1240
    Figure 1: 179
    Figure 2: 192
    Figure 3: 188
  • The THE PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW: PART 2-FOCUS ON THERAPY

    Michele Bibas
    e2024015
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.015
    1800
    PDF: 1686
    HTML: 892
  • CHLORAMBUCIL PLUS RITUXIMAB AS FRONT-LINE THERAPY IN ELDERLY/UNFIT PATIENTS AFFECTED BY B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A SINGLE-CENTRE EXPERIENCE.

    Luca Laurenti, Barbara Vannata, Idanna Innocenti, Francesco Autore, Francesco Santini, Nicola Piccirillo, Tommaso Za, Silvia Bellesi, Sara Marietti, Simona Sica, Dimitar G. Efremov, Giuseppe Leone
    e2013031
    2013-05-01
    https://doi.org/10.4084/mjhid.2013.031
    3253
    PDF: 913
    HTML: 1543
    Fig.1 CHL-R paper: 226
    Fig 2 CHL-R paper: 246
  • INFECTIONS IN THALASSEMIA AND HEMOGLOBINOPATHIES

    Bianca Maria Ricerca, Arturo Di Girolamo, Deborah Rund
    e2009028
    2009-12-28
    1092
    PDF: 619
    HTML: 4411
  • Evaluation of Hepatitis B and C Reactivation in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors

    Nathalia Sena de Oliveira Silva, Gislaine Duarte, Samuel de Souza Medina, Guilherme Brasil Duffles Amarante, Carmino Antonio de Souza, Katia Borgia Barbosa Pagnano
    e2026001
    2026-01-01
    https://doi.org/10.4084/MJHID.2026.001
    689
    PDF: 513
    Html: 96
  • HIV INFECTION, ANTIRETROVIRAL THERAPY AND CARDIOVASCULAR RISK

    Katleen de Gaetano Donati, Roberto Cauda, Licia Iacoviello
    e2010034
    2010-11-10
    https://doi.org/10.4084/mjhid.2010.034
    1875
    PDF: 806
    HTML: 3608
  • ATYPICAL DERMATOLOGICAL MANIFESTATIONS OF SYPHILIS IN ADVANCED HIV: A CASE-BASED NARRATIVE REVIEW

    Irene Scarvaglieri, Federico Cesanelli, Giorgio Tiecco, Iacopo Ghini, Davide Minisci, Caterina Davoli, Stefano Rapino, Emanuele Focà, Maria Alberti, Martina Salvi, Francesco Castelli, Eugenia Quiros-Roldan
    e2025056
    2025-08-31
    https://doi.org/10.4084/MJHID.2025.056
    1549
    PDF: 916
    HTML: 276
  • IMMUNOLOGICAL EVOLUTION OF A COHORT OF HIV-2 INFECTED PATIENTS: PECULIARITIES OF AN UNDERESTIMATED INFECTION HIV-2 INFECTED PATIENTS PECULIARITIES

    Emanuele Focà, Benedetta Fumarola
    e2022016
    2022-02-27
    https://doi.org/10.4084/MJHID.2022.016
    998
    PDF: 628
    HTML: 233
1 - 19 of 19 items
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.